Figure 4
From: Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
Disease-free survival curve according to BCL2 status in each breast cancer subtype. HRc(+)/HER2(−) (A), HRc(+)/HER2(+) (B), HRc(−)/HER2(+) (C), and HRc(−)/HER2(−) (D). Abbreviation: HER2, human epidermal growth factor receptor 2; HRc, hormone receptor; PS, proportion score.
